Concert Bio
PrivateLast Round
Accelerator
Oct 30, 2024
Total Funding Raised
$7.46M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Concert Bio is a biotechnology company that develops microbiome monitoring and optimization tools, including beneficial microbe products, for hydroponic greenhouse growers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Concert Bio Comparables
Compare Concert Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ceragen | 80% | |
| BioConsortia, Inc. | 80% | |
| Boost Biomes | 76% |
Concert Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 30, 2024 | ||||
| Grant | Dec 5, 2023 | ||||
| Seed | Nov 1, 2023 | ||||
| Grant | Nov 1, 2023 | ||||
| Pre Seed | Aug 1, 2022 |
Key People
Founding team and executive leadership
Concert Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Nucleus Capital | Pre Seed |
| Ascension Ventures | Seed |
| EQT Foundation | Accelerator, Seed |
| Climate Capital | Pre Seed |
| Ponderosa Ventures | Pre Seed |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 578% MoM, reaching 1.2K.
- Jan 1, 2026
Operates research greenhouse facilities at the University of Warwick Innovation Campus.
Concert Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Concert Bio's valuation, stock price, and market status.
Is Concert Bio a public or private company?
Concert Bio is a private company.
What is the current stock price of Concert Bio?
Concert Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Concert Bio worth (valuation)?
Valuation information for Concert Bio is not publicly available.
Can I buy Concert Bio stock?
Concert Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Concert Bio's last funding round?
Concert Bio's most recent funding round was Seed on October 7, 2024.
Who are the main investors in Concert Bio?
Key investors in Concert Bio include The Venture Collective.
Will Concert Bio IPO soon?
No public IPO plans have been announced for Concert Bio.
How can I track Concert Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Concert Bio's secondary market activity and sign up for updates.